Abiopharma

🔍 McBee Brannin (Executive)

Company: CoreWeave, Inc. (CRWV)

Report Date: 2026-04-27

Detailed Transactions and Holdings:

• Acquired 200,000 shares of Class A Common Stock (Direct)
  Date: 2026-04-27 | Code: C | equity_swap_involved: 0 | shares_owned_after: 513,732.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 16,300 shares of Class A Common Stock at $105.6318 per share (Direct)
  Date: 2026-04-27 | Code: S | equity_swap_involved: 0 | shares_owned_after: 497,432.00 | transaction_form_type: 4 | Footnotes: F2, F3
• Sold 23,633 shares of Class A Common Stock at $106.6164 per share (Direct)
  Date: 2026-04-27 | Code: S | equity_swap_involved: 0 | shares_owned_after: 473,799.00 | transaction_form_type: 4 | Footnotes: F2, F4
• Sold 52,711 shares of Class A Common Stock at $107.4897 per share (Direct)
  Date: 2026-04-27 | Code: S | equity_swap_involved: 0 | shares_owned_after: 421,088.00 | transaction_form_type: 4 | Footnotes: F2, F5
• Sold 12,451 shares of Class A Common Stock at $108.6144 per share (Direct)
  Date: 2026-04-27 | Code: S | equity_swap_involved: 0 | shares_owned_after: 408,637.00 | transaction_form_type: 4 | Footnotes: F2, F6
• Sold 9,175 shares of Class A Common Stock at $109.6284 per share (Direct)
  Date: 2026-04-27 | Code: S | equity_swap_involved: 0 | shares_owned_after: 399,462.00 | transaction_form_type: 4 | Footnotes: F2, F7
• Sold 30,331 shares of Class A Common Stock at $110.8 per share (Direct)
  Date: 2026-04-27 | Code: S | equity_swap_involved: 0 | shares_owned_after: 369,131.00 | transaction_form_type: 4 | Footnotes: F2, F8
• Sold 48,600 shares of Class A Common Stock at $111.4776 per share (Direct)
  Date: 2026-04-27 | Code: S | equity_swap_involved: 0 | shares_owned_after: 320,531.00 | transaction_form_type: 4 | Footnotes: F2, F9
• Sold 6,799 shares of Class A Common Stock at $112.1837 per share (Direct)
  Date: 2026-04-27 | Code: S | equity_swap_involved: 0 | shares_owned_after: 313,732.00 | transaction_form_type: 4 | Footnotes: F2, F10
• Acquired 33,350 shares of Class A Common Stock (Direct)
  Date: 2026-04-27 | Code: C | equity_swap_involved: 0 | shares_owned_after: 33,350.00 | transaction_form_type: 4 | Footnotes: F1, F11
• Sold 2,668 shares of Class A Common Stock at $105.6106 per share (Direct)
  Date: 2026-04-27 | Code: S | equity_swap_involved: 0 | shares_owned_after: 30,682.00 | transaction_form_type: 4 | Footnotes: F2, F12, F11
• Sold 3,682 shares of Class A Common Stock at $106.5702 per share (Direct)
  Date: 2026-04-27 | Code: S | equity_swap_involved: 0 | shares_owned_after: 27,000.00 | transaction_form_type: 4 | Footnotes: F2, F13, F11
• Sold 9,242 shares of Class A Common Stock at $107.4854 per share (Direct)
  Date: 2026-04-27 | Code: S | equity_swap_involved: 0 | shares_owned_after: 17,758.00 | transaction_form_type: 4 | Footnotes: F2, F14, F11
• Sold 1,890 shares of Class A Common Stock at $108.616 per share (Direct)
  Date: 2026-04-27 | Code: S | equity_swap_involved: 0 | shares_owned_after: 15,868.00 | transaction_form_type: 4 | Footnotes: F2, F15, F11
• Sold 1,484 shares of Class A Common Stock at $109.5084 per share (Direct)
  Date: 2026-04-27 | Code: S | equity_swap_involved: 0 | shares_owned_after: 14,384.00 | transaction_form_type: 4 | Footnotes: F2, F16, F11
• Sold 4,852 shares of Class A Common Stock at $110.7695 per share (Direct)
  Date: 2026-04-27 | Code: S | equity_swap_involved: 0 | shares_owned_after: 9,532.00 | transaction_form_type: 4 | Footnotes: F2, F17, F11
• Sold 7,844 shares of Class A Common Stock at $111.4261 per share (Direct)
  Date: 2026-04-27 | Code: S | equity_swap_involved: 0 | shares_owned_after: 1,688.00 | transaction_form_type: 4 | Footnotes: F2, F18, F11
• Sold 1,688 shares of Class A Common Stock at $112.1269 per share (Direct)
  Date: 2026-04-27 | Code: S | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F2, F19, F11
• Acquired 54,150 shares of Class A Common Stock (Direct)
  Date: 2026-04-27 | Code: C | equity_swap_involved: 0 | shares_owned_after: 54,150.00 | transaction_form_type: 4 | Footnotes: F1, F20
• Sold 4,331 shares of Class A Common Stock at $105.6106 per share (Direct)
  Date: 2026-04-27 | Code: S | equity_swap_involved: 0 | shares_owned_after: 49,819.00 | transaction_form_type: 4 | Footnotes: F2, F12, F20
• Sold 5,979 shares of Class A Common Stock at $106.5701 per share (Direct)
  Date: 2026-04-27 | Code: S | equity_swap_involved: 0 | shares_owned_after: 43,840.00 | transaction_form_type: 4 | Footnotes: F2, F13, F20
• Sold 15,006 shares of Class A Common Stock at $107.4854 per share (Direct)
  Date: 2026-04-27 | Code: S | equity_swap_involved: 0 | shares_owned_after: 28,834.00 | transaction_form_type: 4 | Footnotes: F2, F14, F20
• Sold 3,068 shares of Class A Common Stock at $108.6158 per share (Direct)
  Date: 2026-04-27 | Code: S | equity_swap_involved: 0 | shares_owned_after: 25,766.00 | transaction_form_type: 4 | Footnotes: F2, F15, F20
• Sold 2,411 shares of Class A Common Stock at $109.5087 per share (Direct)
  Date: 2026-04-27 | Code: S | equity_swap_involved: 0 | shares_owned_after: 23,355.00 | transaction_form_type: 4 | Footnotes: F2, F16, F20
• Sold 7,877 shares of Class A Common Stock at $110.7695 per share (Direct)
  Date: 2026-04-27 | Code: S | equity_swap_involved: 0 | shares_owned_after: 15,478.00 | transaction_form_type: 4 | Footnotes: F2, F17, F20
• Sold 12,737 shares of Class A Common Stock at $111.4261 per share (Direct)
  Date: 2026-04-27 | Code: S | equity_swap_involved: 0 | shares_owned_after: 2,741.00 | transaction_form_type: 4 | Footnotes: F2, F18, F20
• Sold 2,741 shares of Class A Common Stock at $112.1271 per share (Direct)
  Date: 2026-04-27 | Code: S | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F2, F19, F20
• Sold 200,000 shares of Class B Common Stock (Derivative)
  Date: 2026-04-27 | Code: C | equity_swap_involved: 0 | shares_owned_after: 6,991,660.00 | transaction_form_type: 4 | Footnotes: F1, F1, F1, F1
• Sold 33,350 shares of Class B Common Stock (Derivative)
  Date: 2026-04-27 | Code: C | equity_swap_involved: 0 | shares_owned_after: 2,080,300.00 | transaction_form_type: 4 | Footnotes: F1, F1, F1, F1, F11
• Sold 54,150 shares of Class B Common Stock (Derivative)
  Date: 2026-04-27 | Code: C | equity_swap_involved: 0 | shares_owned_after: 3,641,020.00 | transaction_form_type: 4 | Footnotes: F1, F1, F1, F1, F20

Footnotes:

• F1: Each share of Class B Common Stock is convertible into one share of the Issuer's Class A Common Stock at any time, at the election of the holder or automatically upon certain transfers, whether or not for value, or upon the occurrence of certain events or conditions described in the Issuer's Amended and Restated Certificate of Incorporation.
• F2: The reported transaction represents a sale effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 17, 2025.
• F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $105.05 to $106.04, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this filing.
• F4: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $106.05 to $107.04, inclusive.
• F5: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $107.05 to $108.04, inclusive.
• F6: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $108.05 to $109.04, inclusive.
• F7: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $109.05 to $110.04, inclusive.
• F8: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $110.06 to $111.055, inclusive.
• F9: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $111.06 to $112.05, inclusive.
• F10: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $112.06 to $112.82, inclusive.
• F11: The reported securities are directly held by the reporting person's spouse.
• F12: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $105.02 to $105.97, inclusive.
• F13: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $106.02 to $107.01, inclusive.
• F14: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $107.02 to $108.01, inclusive.
• F15: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $108.02 to $108.93, inclusive.
• F16: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $109.02 to $109.995, inclusive.
• F17: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $110.03 to $111.02, inclusive.
• F18: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $111.03 to $112.02, inclusive.
• F19: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $112.03 to $112.76, inclusive.
• F20: The reported securities are directly held by the Brannin J. McBee 2022 Irrevocable Trust, of which the reporting person's spouse and minor child are beneficiaries and for which the reporting person's spouse serves as trustee.
• REMARKS: This Form 4 is Part 1 of 2 for this reporting person. Transactions by the reporting person are continued on Part 2.